首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

2092285

病患監測設備市場：全球市場預測（2026-2032 年）

Patient Monitoring Devices Market - Global Forecast 2026-2032

出版日期: 2026年07月16日 | 出版商:

360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

預計到 2032 年，病患監測設備市場規模將達到 897.5 億美元，複合年成長率為 8.15%。

主要市場統計數據
基準年（2025 年）	518.5億美元
預計年份（2026年）	559.4億美元
預測年份（2032年）	897.5億美元
複合年成長率（）	8.15%

隨著醫院、門診診所、居家醫療保健機構和遠端醫療計畫對持續、及時且具有臨床應用價值的患者資料的需求日益成長，病患監測設備正成為現代醫療保健服務的重要組成部分。這類設備包括多參數床邊監視器、心電圖監視器、脈搏血氧飽和度分析儀、血壓監視器、呼吸監視器、體溫監測系統、胎兒和新生兒監視器、血糖監測技術、穿戴式患者監護儀、遠端患者監護平台。推動這項需求的因素包括慢性病負擔加重、人口老化、外科手術數量增加、重症監護和急診醫學的擴張以及醫療模式向分散式醫療模式的轉變。經證實的公共衛生檢驗表明，心血管疾病仍然是全球首要死因，糖尿病持續影響著數億成年人，慢性呼吸系統疾病是主要的致病因素，這些因素共同造就了對精準、連網監護的持續臨床需求。同時，數位醫療的普及、遠端醫療報銷制度的改革以及對互通性的期望，正在加速從一次性測量到連續監測的轉變。對於醫療機構而言，病患監測設備目前支持早期發現病情惡化、急性期後的後續觀察、藥物劑量調整、任務優先排序以及院內和家庭環境中的護理協調。

病患監測領域的變革性變化

病患監測設備領域正經歷結構性變革，從獨立硬體轉變為具備連接性和軟體功能的生態系統。儘管傳統的床邊加護病房、手術室、急診科和過渡病房仍然至關重要，但醫療機構正擴大整合無線感測器、雲端儀錶板、移動警報以及與電子健康記錄的整合，以將監護範圍擴展到固定的臨床環境之外。隨著醫療系統致力於慢性病管理、減少可避免的再入院以及支持居家養老策略，遠端患者監護的重要性日益凸顯。監管機構也提高了對網路安全、軟體生命週期管理、資料完整性和上市後監管的要求，尤其是在設備聯網並利用演算法的情況下。另一個變革性的轉變是從以設備為中心的採購轉向以結果為導向的部署，決策者現在會評估臨床準確性、警報管理、易用性、互通性、電池性能、患者依從性以及對整體工作流程的影響。醫院優先考慮能夠減少警報疲勞並與臨床決策支援系統整合的解決方案，而保險公司和醫療服務提供者則越來越注重根據患者參與情況、臨床醫生評估和可衡量的護理干預措施來評估遠距監測項目。這些轉變正在重新定義競爭優勢，不再只專注於硬體規格，而是轉向可靠性、整合性、證據產生和服務主導的部署。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善訊號處理、模式識別、風險分層和臨床工作流程中的分診，對病患監測設備整體產生累積影響。在穿戴式裝置和床邊監護中，經適當臨床資料檢驗的 AI 演算法可以幫助過濾運動偽影、識別心律不整模式、檢測呼吸惡化徵兆併計算早期預警評分。在遠端患者監護中，AI 透過將生理數據與患者報告的結果、用藥資訊和歷史趨勢相結合，對警報進行優先排序，幫助臨床醫生專注於最有可能需要干預的患者。然而，AI 在病患監測中的價值取決於透明的檢驗、代表性的資料集、人工監督和監管合規性。衛生監管機構和標準化組織越來越重視醫療設備的軟體管治、可解釋性、網路安全措施和實際性能監測。減少偏差也至關重要，因為設備的準確性會受到膚色、血流、運動、年齡、共病和護理環境等因素的影響。短期來看，人工智慧最實際的應用並非自主診斷，而是在臨床醫生指導下提供決策支援、預測病情惡化、輔助自動文件記錄以及最佳化警報系統。將人工智慧與可互通的資料架構、以臨床醫生為中心的設計以及嚴格的臨床檢驗相結合的機構，更有能力從持續的病患監測中獲得可靠的洞見。

按主要區域分析

在亞太地區，中國、印度、日本、韓國和澳洲等國家受到許多強勁因素的推動，這些因素促進了病患監測設備的普及應用，包括龐大的人口基數、日益加重的非傳染性疾病負擔、對醫院基礎設施的投資以及數位醫療的快速發展。該地區的需求涵蓋了從都市區醫院的高級重症監護到可擴展的遠端患者監護，涵蓋糖尿病、高血壓、心臟病、產科護理和老年護理等領域。北美在互聯監護方面仍然處於高度發達的水平，這得益於醫院的廣泛數位化、遠端醫療的應用、遠距生理監護的保險報銷機制，以及對醫療保健和家庭環境中心臟和呼吸系統疾病以及慢性病監測的強勁需求。在拉丁美洲，擴大和現代化臨床基礎設施是當務之急，巴西和墨西哥對生命徵象監測、孕產婦和新生兒監測以及慢性病監測的需求顯著成長，公共和私營醫療系統正努力縮小醫療保健差距。歐洲的特徵是人口老化、醫院體系完善、跨境法規協調一致，以及高度重視醫療設備法規下的資料保護、互通性和臨床證據。在中東，尤其是在海灣國家的醫療保健體系中，醫院現代化、數位健康平台和專科醫療保健系統方面的投資正在不斷推進，遠端監測在慢性病管理和預防保健工作中的重要性日益凸顯。非洲的情況則更為複雜，病患監測的需求與重症監護系統的發展、孕產婦和新生兒健康、感染疾病控制以及行動醫療服務密切相關。經濟性、耐用性、電力穩定性、培訓和服務支援仍然是部署的關鍵考慮因素。

主要群體分析

在東協市場，由於醫院網路不斷擴張、慢性病盛行率上升以及政府主導的數位化醫療舉措，病患監測的應用正在加速發展。市場對價格適中的多參數監視器、母嬰設備以及行動連線遠距監護設備的實際需求日益成長。海灣合作理事會（GCC）成員國的特點是醫療基礎設施快速發展、高度重視數位轉型，以及糖尿病、心血管疾病和肥胖症負擔日益加重，這些因素推動了先進醫院監護系統和慢性病監測工具的應用。歐盟是一個監管嚴格且以循證醫學為基礎的地區，透過醫療設備合規性、數據隱私要求、互通性標準以及對數位化醫療和老齡化社會護理的政策支持，正在影響病患監測設備的普及。金磚國家的需求環境多樣但具有重要的戰略意義，它們既有龐大的患者群體、擴大醫療服務覆蓋範圍、慢性病患病率上升以及加強國內醫療技術能力等國家優先事項，又在採購模式、基礎設施成熟度和報銷機制方面存在顯著差異。由於七國集團（G7）國家擁有高度數位化的醫院、完善的專業醫療保健體係以及對遠端患者監護的高度接受度，它們在互聯監護的臨床應用方面通常處於領先地位。然而，它們也必須滿足有關安全性、網路安全和臨床性能的嚴格要求。北約成員國與北美和歐洲的醫療已開發經濟體高度重合，在這些國家，韌性、網路安全、供應鏈保障和互通性對於醫療系統的採購決策至關重要，因為這些系統即使在緊急情況和公共衛生危機期間也必須保持服務的連續性。

主要國家的概況

美國憑藉其成熟的醫院網路、強大的數位醫療基礎設施、慢性病管理需求以及完善的遠距生理監測報銷機制（前提是滿足臨床要求），在病患監測設備的普及應用方面主導。加拿大注重互聯醫療、覆蓋偏遠地區以及慢性病管理，這催生了對可靠的遠距監護設備和適用於其地理分散人口的醫院級設備的需求。在墨西哥，隨著公共和私人醫療系統的現代化，需求不斷成長，重點關注生命徵象監測、孕產婦保健、心血管監測和糖尿病相關監測。巴西大規模的醫療體系和沈重的慢性病負擔推動了醫院級監視器、穿戴式裝置和基層醫療照護技術的持續普及，尤其是在循環系統、重症監護和遠端醫療追蹤領域。英國注重醫療衛生消毒、支援虛擬病房以及在醫院外管理慢性病，這與遠端患者監護、居家血氧飽和度測量和互聯生命徵象解決方案的需求相契合。德國先進的醫院體系和嚴格的監管要求推動了對高精度監測設備、互通性、網路安全和循證數位健康應用的需求。在法國，數位健康的整合和慢性病管理流程的進步推動了循環系統、糖尿病、呼吸系統疾病和急性後期追蹤等領域互聯監測技術的應用。俄羅斯的需求受到醫院基礎建設、區域醫療資源分配不均、心血管疾病負擔以及對國內醫療技術韌性的擔憂等因素的影響。義大利和西班牙都面臨著人口老化和慢性病管理的壓力，這促使兩國加速在利用醫院、復健中心、居家醫療和遠端醫療資源的計畫中採用病患監測技術。在中國，大規模醫院的現代化、數位健康的快速普及、人口老化以及慢性病的高發生率共同推動了互聯病患監測在三級醫療和社區醫療管理中發揮核心作用。印度的需求主要源自於其龐大的人口基數、日益加重的糖尿病和心血管疾病負擔、私人醫療保健的擴張、公共數位健康舉措的推進，以及對醫院、診所和居家醫療等各環節進行經濟高效監測的需求。在日本，超老化社會和先進的臨床基礎設施使得遠端監測、心電圖監測、跌倒風險監測和居家慢性病照護特別重要。在澳大利亞，人口地理分散，推動了遠端醫療監測、遠距照護模式和慢性病管理的發展，尤其是在農村和地方社區。在韓國，強大的數位基礎設施、先進的醫院和較高的技術普及率為互聯監測、人工智慧驅動的分析和綜合慢性病護理模式提供了支持。

為行業領導者提供的實用建議

行業領導者應優先考慮經過臨床檢驗、互通性且安全的病患監測設備，這些設備應與醫院、門診診所和家庭環境中的實際工作流程相契合。產品策略應著重於減少警報疲勞、提高感測器精度、簡化設定、提供多語言且易於存取的使用者介面，以及實現與電子健康記錄和虛擬醫療平台的無縫資料交換。證據生成至關重要。各機構應投資於同儕審查檢驗、可用性研究、上市後性能監測以及衛生經濟學證據，以證明這些設備能夠改善護理協調、實現早期療育、減少不必要的醫療保健使用或改善慢性病管理。對於遠端患者監護，領導者應設計包含患者入職、依從性支援、設備物流、升級流程以及與臨床醫生工作流程整合的服務模式，而不是僅依賴硬體部署。網路安全和隱私保護應從設計階段就融入其中，包括安全性身份驗證、加密、漏洞管理、軟體更新管治以及遵守適用的本地資料保護要求。銷售團隊需要根據不同的醫療機構和地區調整產品和服務，在提供醫院級高品質解決方案的同時，兼顧資源有限環境下的耐用、經濟且易於維護的設備。與醫療服務提供者、數位醫療平台、保險公司和公共衛生計畫夥伴關係，能夠加速產品部署，並以透明的結果和永續的部署模式為支持。

分析方法

本報告基於結構化的二手分析方法，參考了檢驗的公共和機構資訊來源，包括衛生部門出版刊物、監管指南、臨床標準、同行評審文獻、醫院數位健康政策文件以及公開的疾病負擔證據。分析整合了慢性病盛行率、人口老化、遠距遠端醫療和遠端患者監護的普及、醫療設備法規、互通性要求、網路安全預期以及醫療服務模式轉型等方面的資訊。區域、群體和國家層面的洞察是基於已記錄的醫療基礎設施趨勢、公共衛生優先事項、數位健康成熟度和法規環境，而非市場規模估算或預測。此分析方法強調交叉引用多個可靠資訊來源，以確保一致性和相關性，並排除檢驗的說法、宣傳標語和未經證實的數值預測。透過對醫療設備類別、醫療環境、最終用戶以及推廣障礙（例如準確性、易用性、連接性、經濟性、報銷、數據管治以及與臨床工作流程的整合）進行定性證據映射，評估關鍵主題。這種方法能夠提供基於證據的病患監測設備現狀洞察，避免推測性假設，並專注於可操作的行業資訊。

結論

病患監測設備正從一次性測量工具發展成為支持跨醫院、診所和家庭環境的連續性照護的互聯臨床智慧系統。精準感測器、互通平台、檢驗的分析技術和以臨床醫生為中心的工作流程的融合，為改善及時干預和慢性病管理創造了最大機會。人工智慧、遠端患者監護、穿戴式裝置和虛擬護理模式正在拓展監護的作用，但它們的廣泛應用取決於可靠性、循證性、網路安全、經濟性和合規性。區域趨勢差異顯著。先進的醫療保健系統專注於整合、工作流程最佳化和居家醫療，而新興市場則優先考慮可及性、耐用性、成本效益和基礎設施可用性。能夠建立臨床可靠、安全且擴充性的監護解決方案，並輔以強大的部署服務和經證實的成果的行業領導者，將最有能力滿足下一代醫療保健需求。病患監測的未來不僅取決於設備創新，還取決於將連續生理數據轉化為可行、公平和永續的醫療保健服務的能力。

A&D Company, Limited
Abbott Laboratories
Analogic Corporation
Baxter International Inc.
Becton Dickinson and Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Contec Medical Systems Co., Ltd.
Dexcom, Inc.
Draegerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Fukuda Denshi Co., Ltd.
GE HealthCare
Getinge AB
Hill-Rom Holdings, Inc.
iRhythm Technologies, Inc.
Koninklijke Philips NV
Masimo Corporation
Medtronic plc
Nihon Kohden Corporation
Nonin Medical, Inc.
Omron Healthcare Co., Ltd.
ResMed Inc.
Schiller AG
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
Spacelabs Healthcare, Inc.
SunTech Medical, Inc.
VitalConnect, Inc.

A&D Company, Limited
Abbott Laboratories
Analogic Corporation
Baxter International Inc.
Becton Dickinson and Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Contec Medical Systems Co., Ltd.
Dexcom, Inc.
Draegerwerk AG & Co. KGaA
Edwards Lifesciences Corporation
Fukuda Denshi Co., Ltd.
GE HealthCare
Getinge AB
Hill-Rom Holdings, Inc.
iRhythm Technologies, Inc.
Koninklijke Philips NV
Masimo Corporation
Medtronic plc
Nihon Kohden Corporation
Nonin Medical, Inc.
Omron Healthcare Co., Ltd.
ResMed Inc.
Schiller AG
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
Spacelabs Healthcare, Inc.
SunTech Medical, Inc.
VitalConnect, Inc.

簡介目錄圖表

Product Code: MRR-FB6C9E792B43

The Patient Monitoring Devices Market is projected to grow by USD 89.75 billion at a CAGR of 8.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 51.85 billion
Estimated Year [2026]	USD 55.94 billion
Forecast Year [2032]	USD 89.75 billion
CAGR (%)	8.15%

Patient monitoring devices are becoming a critical layer of modern healthcare delivery as hospitals, ambulatory centers, home care providers, and virtual care programs seek continuous, timely, and clinically actionable patient data. The category spans multiparameter bedside monitors, cardiac monitoring devices, pulse oximeters, blood pressure monitors, respiratory monitors, temperature monitoring systems, fetal and neonatal monitors, glucose monitoring technologies, wearable patient monitors, and remote patient monitoring platforms. Demand is being shaped by the rising burden of chronic diseases, population aging, higher surgical volumes, expansion of intensive and emergency care, and the shift toward decentralized care models. Verified public health evidence shows that cardiovascular diseases remain the leading cause of death globally, diabetes continues to affect hundreds of millions of adults, and chronic respiratory conditions are major contributors to morbidity, creating sustained clinical need for accurate, connected monitoring. At the same time, digital health adoption, telehealth reimbursement reforms, and interoperability expectations are accelerating the transition from episodic measurement to longitudinal monitoring. For healthcare organizations, patient monitoring devices now support early deterioration detection, post-acute surveillance, medication titration, workflow prioritization, and care coordination across in-facility and home-based settings.

Transformative Shifts in the Patient Monitoring Landscape

The patient monitoring devices landscape is undergoing a structural transformation from standalone hardware toward connected, software-enabled ecosystems. Traditional bedside monitoring remains essential in critical care, operating rooms, emergency departments, and step-down units, but healthcare providers are increasingly integrating wireless sensors, cloud-based dashboards, mobile alerts, and electronic health record connectivity to extend monitoring beyond fixed clinical environments. Remote patient monitoring is gaining relevance as health systems manage chronic disease, reduce avoidable readmissions, and support aging-in-place strategies. Regulatory authorities have also elevated expectations for cybersecurity, software lifecycle management, data integrity, and post-market surveillance, particularly as devices become networked and algorithm-enabled. Another transformative shift is the movement from device-centric procurement to outcome-oriented deployment, where decision-makers evaluate clinical accuracy, alarm management, usability, interoperability, battery performance, patient adherence, and total workflow impact. Hospitals are prioritizing solutions that reduce alarm fatigue and integrate with clinical decision support, while payers and providers increasingly assess remote monitoring programs based on documented engagement, clinician review, and measurable care interventions. These shifts are redefining competitive differentiation around reliability, integration, evidence generation, and service-enabled implementation rather than hardware specifications alone.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative impact across patient monitoring devices by improving signal processing, pattern recognition, risk stratification, and clinical workflow triage. In wearable and bedside monitoring, AI-enabled algorithms can help filter motion artifacts, identify arrhythmia patterns, detect respiratory deterioration signals, and support early warning scores when validated against appropriate clinical datasets. In remote patient monitoring, AI can prioritize alerts by combining physiologic data with patient-reported outcomes, medication information, and historical trends, helping clinicians focus on patients most likely to require intervention. However, the value of AI in patient monitoring depends on transparent validation, representative datasets, human oversight, and regulatory compliance. Health authorities and standards bodies increasingly emphasize software as a medical device governance, explainability, cybersecurity controls, and real-world performance monitoring. Bias mitigation is also essential because device accuracy can be affected by factors such as skin tone, perfusion, movement, age, comorbidities, and care setting. The most practical near-term AI opportunities are not autonomous diagnosis but clinically supervised decision support, predictive analytics for deterioration, automated documentation support, and alarm optimization. Organizations that combine AI with interoperable data architecture, clinician-centered design, and rigorous clinical validation are better positioned to generate trustworthy insights from continuous patient monitoring.

Key Regional Insights

Asia-Pacific is experiencing strong adoption drivers for patient monitoring devices due to large populations, growing noncommunicable disease burdens, hospital infrastructure investments, and rapid digital health expansion in countries such as China, India, Japan, South Korea, and Australia. The region's needs range from advanced intensive care monitoring in urban hospitals to scalable remote patient monitoring for diabetes, hypertension, cardiac disease, maternal care, and elder care. North America remains a highly advanced environment for connected monitoring, supported by widespread hospital digitization, telehealth utilization, reimbursement pathways for remote physiologic monitoring, and strong demand for cardiac, respiratory, and chronic disease monitoring across institutional and home settings. Latin America is prioritizing access expansion and modernization of clinical infrastructure, with Brazil and Mexico showing significant demand for vital signs monitoring, maternal and neonatal monitoring, and chronic disease surveillance as public and private systems address uneven care access. Europe is shaped by aging populations, established hospital systems, cross-border regulatory harmonization, and strong emphasis on data protection, interoperability, and clinical evidence under medical device regulations. The Middle East is investing in hospital modernization, digital health platforms, and specialty care capacity, particularly across Gulf health systems, while remote monitoring is increasingly relevant for chronic disease management and preventive care initiatives. Africa presents a diverse landscape where patient monitoring demand is linked to critical care capacity building, maternal and neonatal health, infectious disease management, and mobile-enabled health delivery, with affordability, durability, power reliability, training, and service support remaining key adoption considerations.

Key Group Insights

ASEAN markets are advancing patient monitoring adoption through expanding hospital networks, rising chronic disease prevalence, and government-backed digital health initiatives, with practical demand for affordable multiparameter monitors, maternal and neonatal devices, and mobile-connected remote monitoring. The GCC is characterized by rapid healthcare infrastructure development, high prioritization of digital transformation, and elevated burden of diabetes, cardiovascular disease, and obesity, supporting adoption of advanced hospital monitoring systems and chronic disease surveillance tools. The European Union is a highly regulated and evidence-driven group where patient monitoring device adoption is influenced by medical device compliance, data privacy requirements, interoperability standards, and policy support for digital health and aging population care. BRICS countries represent heterogeneous but strategically important demand environments, combining large patient populations, expanding healthcare access, chronic disease growth, and national priorities for domestic medical technology capacity, although procurement models, infrastructure maturity, and reimbursement mechanisms vary widely. G7 countries generally lead in clinical adoption of connected monitoring due to advanced hospital digitization, established specialty care systems, and higher readiness for remote patient monitoring, while also enforcing rigorous safety, cybersecurity, and clinical performance expectations. NATO member countries overlap significantly with advanced healthcare economies in North America and Europe, where procurement decisions increasingly consider resilience, cybersecurity, supply chain assurance, and interoperability for healthcare systems that must maintain continuity during emergencies and public health disruptions.

Key Country Insights

The United States is a leading adopter of patient monitoring devices due to mature hospital networks, strong digital health infrastructure, chronic disease management needs, and established reimbursement mechanisms for remote physiologic monitoring when clinical requirements are met. Canada emphasizes connected care, rural and remote access, and chronic disease management, creating demand for reliable remote monitoring and hospital-grade devices suited to geographically dispersed populations. Mexico is expanding demand through public and private healthcare modernization, with emphasis on vital signs monitoring, maternal care, cardiovascular monitoring, and diabetes-related surveillance. Brazil's large healthcare system and chronic disease burden support continued adoption of hospital monitors, wearable devices, and telehealth-enabled monitoring, especially in cardiology, intensive care, and primary care follow-up. The United Kingdom is focused on reducing care backlogs, supporting virtual wards, and managing chronic disease outside hospitals, which aligns with remote patient monitoring, home-based oximetry, and connected vital signs solutions. Germany's advanced hospital system and strict regulatory expectations support demand for high-accuracy monitoring devices, interoperability, cybersecurity, and evidence-backed digital health applications. France is advancing digital health integration and chronic disease pathways, supporting adoption of connected monitoring for cardiology, diabetes, respiratory care, and post-acute follow-up. Russia's demand is shaped by hospital infrastructure needs, regional access disparities, cardiovascular disease burden, and interest in domestic medical technology resilience. Italy and Spain both face aging populations and chronic disease management pressures, supporting patient monitoring adoption in hospitals, rehabilitation, home care, and telehealth-supported programs. China combines large-scale hospital modernization, rapid digital health adoption, aging demographics, and high chronic disease prevalence, making connected patient monitoring central to both tertiary care and community health management. India's demand is driven by a large population, growing diabetes and cardiovascular disease burden, expanding private healthcare, public digital health initiatives, and the need for cost-effective monitoring across hospitals, clinics, and home care. Japan's super-aging population and advanced clinical infrastructure make remote monitoring, cardiac monitoring, fall-risk-related monitoring, and home-based chronic care particularly relevant. Australia's geographically dispersed population supports telehealth-linked monitoring, remote care models, and chronic disease management, especially for rural and regional communities. South Korea's strong digital infrastructure, advanced hospitals, and high technology adoption support connected monitoring, AI-enabled analytics, and integrated chronic disease care models.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated, interoperable, and secure patient monitoring devices that align with real-world workflows across hospitals, ambulatory care, and home settings. Product strategies should focus on reducing alarm fatigue, improving sensor accuracy, simplifying setup, supporting multilingual and accessible user interfaces, and enabling seamless data exchange with electronic health records and virtual care platforms. Evidence generation is essential: organizations should invest in peer-reviewed validation, usability studies, post-market performance monitoring, and health economic evidence that demonstrates improved care coordination, earlier intervention, reduced avoidable utilization, or better chronic disease management. For remote patient monitoring, leaders should design service models that include patient onboarding, adherence support, device logistics, escalation protocols, and clinician workflow integration rather than relying on hardware deployment alone. Cybersecurity and privacy should be embedded by design, including secure authentication, encryption, vulnerability management, software update governance, and compliance with applicable regional data protection requirements. Commercial teams should tailor offerings by care setting and region, balancing premium hospital-grade solutions with rugged, affordable, and easy-to-maintain devices for resource-constrained environments. Partnerships with healthcare providers, digital health platforms, payers, and public health programs can accelerate adoption when supported by transparent outcomes and sustainable implementation models.

Research Methodology

This executive summary is developed using a structured secondary research methodology grounded in verified public and institutional sources, including health authority publications, regulatory guidance, clinical standards, peer-reviewed literature, hospital digital health policy documents, and publicly available disease burden evidence. The analysis synthesizes information on chronic disease prevalence, population aging, telehealth and remote patient monitoring adoption, medical device regulation, interoperability requirements, cybersecurity expectations, and care delivery transformation. Regional, group, and country insights are derived from documented healthcare infrastructure trends, public health priorities, digital health maturity, and regulatory environments rather than market sizing or forecasting. The methodology emphasizes triangulation across multiple credible sources to ensure consistency and relevance, with exclusion of unverified claims, promotional statements, and unsupported numerical projections. Key themes are assessed through qualitative evidence mapping across device categories, care settings, end users, and adoption barriers, including accuracy, usability, connectivity, affordability, reimbursement, data governance, and clinical workflow integration. This approach supports an evidence-based view of the patient monitoring devices landscape while avoiding speculative estimates and maintaining focus on actionable industry intelligence.

Conclusion

Patient monitoring devices are evolving from point-in-time measurement tools into connected clinical intelligence systems that support continuous care across hospitals, clinics, and homes. The strongest opportunities are emerging where accurate sensors, interoperable platforms, validated analytics, and clinician-centered workflows converge to improve timely intervention and chronic disease management. Artificial intelligence, remote patient monitoring, wearable devices, and virtual care models are expanding the role of monitoring, but adoption will depend on trust, evidence, cybersecurity, affordability, and regulatory compliance. Regional dynamics differ significantly: advanced healthcare systems are focused on integration, workflow optimization, and home-based care, while emerging markets emphasize access, durability, cost-effectiveness, and infrastructure readiness. Industry leaders that build clinically reliable, secure, and scalable monitoring solutions-supported by strong implementation services and documented outcomes-will be best positioned to meet the next generation of healthcare needs. The future of patient monitoring will be defined not only by device innovation but by the ability to convert continuous physiologic data into actionable, equitable, and sustainable care delivery.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Patient Monitoring Devices Market, by Product Type

7.1. Introduction
7.2. Bedside Monitors
7.3. Central Monitoring Stations
7.4. Fetal Monitors
- 7.4.1. External Monitors
- 7.4.2. Internal Monitors
7.5. Telehealth Monitoring Devices
7.6. Wearable Monitors
- 7.6.1. Finger Clip
- 7.6.2. Patch-Based
- 7.6.3. Wrist-Worn

8. Patient Monitoring Devices Market, by Technology

8.1. Introduction
8.2. Wired
8.3. Wireless

9. Patient Monitoring Devices Market, by Connectivity

9.1. Introduction
9.2. Bluetooth
9.3. Cellular
9.4. Radio Frequency
9.5. Wi-Fi

10. Patient Monitoring Devices Market, by Application

10.1. Introduction
10.2. Blood Pressure Monitoring
10.3. Cardiac Monitoring
10.4. Multiparameter Monitoring
10.5. Respiratory Monitoring
10.6. Temperature Monitoring

11. Patient Monitoring Devices Market, by End User

11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Ambulatory Surgical Centers
11.4. Home Care Settings
11.5. Hospitals

12. Patient Monitoring Devices Market, by Deployment Mode

12.1. Introduction
12.2. Cloud-Based
- 12.2.1. Hybrid Cloud
- 12.2.2. Private Cloud
- 12.2.3. Public Cloud
12.3. On-Premise

13. Patient Monitoring Devices Market, by Region

13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa

14. Patient Monitoring Devices Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Patient Monitoring Devices Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
- 16.3.1. Concentration Ratio (CR)
- 16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025

17. Company Profiles

17.1. A&D Company, Limited
17.2. Abbott Laboratories
17.3. Analogic Corporation
17.4. Baxter International Inc.
17.5. Becton Dickinson and Company
17.6. Biotronik SE & Co. KG
17.7. Boston Scientific Corporation
17.8. Cardinal Health, Inc.
17.9. Contec Medical Systems Co., Ltd.
17.10. Dexcom, Inc.
17.11. Draegerwerk AG & Co. KGaA
17.12. Edwards Lifesciences Corporation
17.13. Fukuda Denshi Co., Ltd.
17.14. GE HealthCare
17.15. Getinge AB
17.16. Hill-Rom Holdings, Inc.
17.17. iRhythm Technologies, Inc.
17.18. Koninklijke Philips N.V.
17.19. Masimo Corporation
17.20. Medtronic plc
17.21. Nihon Kohden Corporation
17.22. Nonin Medical, Inc.
17.23. Omron Healthcare Co., Ltd.
17.24. ResMed Inc.
17.25. Schiller AG
17.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.27. Siemens Healthineers AG
17.28. Spacelabs Healthcare, Inc.
17.29. SunTech Medical, Inc.
17.30. VitalConnect, Inc.

簡介目錄圖表

LIST OF FIGURES

FIGURE 1. GLOBAL PATIENT MONITORING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PATIENT MONITORING DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PATIENT MONITORING DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PATIENT MONITORING DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PATIENT MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL PATIENT MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

TABLE 1. GLOBAL PATIENT MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BEDSIDE MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BEDSIDE MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BEDSIDE MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CENTRAL MONITORING STATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CENTRAL MONITORING STATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CENTRAL MONITORING STATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FETAL MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FETAL MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FETAL MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL EXTERNAL MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL EXTERNAL MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EXTERNAL MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INTERNAL MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INTERNAL MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INTERNAL MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TELEHEALTH MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TELEHEALTH MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TELEHEALTH MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL WEARABLE MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL WEARABLE MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL WEARABLE MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FINGER CLIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FINGER CLIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FINGER CLIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PATCH-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PATCH-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PATCH-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL WRIST-WORN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL WRIST-WORN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL WRIST-WORN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL WIRED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL WIRED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WIRED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WIRELESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WIRELESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL WIRELESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLUETOOTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLUETOOTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLUETOOTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CELLULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CELLULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CELLULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RADIO FREQUENCY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RADIO FREQUENCY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RADIO FREQUENCY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL WI-FI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL WI-FI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL WI-FI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD PRESSURE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIAC MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIAC MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIAC MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MULTIPARAMETER MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MULTIPARAMETER MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MULTIPARAMETER MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TEMPERATURE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TEMPERATURE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TEMPERATURE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 130. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 150. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 153. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 156. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 165. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 167. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 170. ASEAN PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 171. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 174. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 175. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 177. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 180. GCC PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 191. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 194. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 195. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 197. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 200. BRICS PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 201. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 204. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 205. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 206. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 207. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 210. G7 PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 211. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 214. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 215. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 217. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 220. NATO PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 232. CANADA PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 235. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 236. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 238. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 241. CANADA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 242. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 245. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 246. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 247. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 248. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 251. MEXICO PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 252. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 255. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 256. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 258. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 261. BRAZIL PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 272. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 274. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 275. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 276. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 278. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 281. GERMANY PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 282. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 285. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 286. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 288. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 291. FRANCE PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 292. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 295. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 296. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 297. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 298. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 299. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 301. RUSSIA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 302. ITALY PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 303. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 304. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 305. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 306. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 307. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 308. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 309. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 310. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 311. ITALY PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 312. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 313. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 314. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 315. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 316. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 317. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 318. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 319. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 321. SPAIN PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 322. CHINA PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 323. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 324. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 325. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 326. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 327. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 328. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 329. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 330. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 331. CHINA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 332. INDIA PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 334. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 335. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 336. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 337. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 338. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 339. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 340. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 341. INDIA PATIENT MONITORING DEVICES MARKET SIZE, BY CLOUD-BASED, 2018-2032 (USD MILLION)
TABLE 342. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 343. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 344. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, BY FETAL MONITORS, 2018-2032 (USD MILLION)
TABLE 345. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORS, 2018-2032 (USD MILLION)
TABLE 346. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 347. JAPAN PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY,